PARTI Overview We are engaged in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal ( GI ) diseases. Non-systemic therapies are non-absorbable drugs that act locally, i.e., in the intestinal lumen, skin or mucosa, without reaching an individuals systemic circulation. In May 2024, we changed our name from First Wave Biopharma, Inc. to Entero Therapeutics, Inc. We are currently focused on developing the biologic Adrulipase, a recomb...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-01 | 2024-12-31 | 0001410578-25-000618 | EDGAR | 84K words |
| 2024-03-29 | 2023-12-31 | 0001410578-24-000364 | EDGAR | — |
| 2023-03-20 | 2022-12-31 | 0001410578-23-000299 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001140361-22-012347 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001654954-21-003659 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001654954-20-003530 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001654954-19-003863 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001654954-18-002715 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001654954-17-002925 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-19 | 2025-09-30 | 0001104659-25-114181 | EDGAR | 34K words |
| 2025-08-14 | 2025-06-30 | 0001410578-25-001790 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001410578-25-001311 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001410578-24-001914 | EDGAR | — |
| 2024-10-21 | 2024-06-30 | 0001410578-24-001685 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001410578-24-000826 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001410578-23-002410 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001410578-23-001882 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001410578-23-001056 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001410578-22-003295 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001410578-22-002519 | EDGAR | — |
| 2022-05-23 | 2022-03-31 | 0001410578-22-001818 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-01-07 | 0001104659-26-001755 | EDGAR | 3K words |
| 2025-12-23 | 0001104659-25-124213 | EDGAR | — |
| 2025-12-04 | 0001104659-25-118524 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107715 | EDGAR | — |
| 2025-10-31 | 0001104659-25-104917 | EDGAR | — |
| 2025-10-22 | 0001104659-25-101519 | EDGAR | — |
| 2025-10-06 | 0001104659-25-097138 | EDGAR | — |
| 2025-09-12 | 0001104659-25-089562 | EDGAR | — |
| 2025-09-09 | 0001104659-25-088663 | EDGAR | — |
| 2025-08-15 | 0001104659-25-079322 | EDGAR | — |
319 total filings indexed. 288 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001604191 |
| Ticker | GRDX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.enterothera.com |
| Listed | 2016-10-11 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report